Celularity Inc. Liabilities, Fair Value Adjustment
Celularity Inc. (CELU) reported Liabilities, Fair Value Adjustment of -$73.03 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:LiabilitiesFairValueAdjustment · last filed 2022-11-10
- Celularity Inc. liabilities, fair value adjustment for the quarter ending 2022-09-30 was -$33.44M.
- Celularity Inc. liabilities, fair value adjustment for the quarter ending 2022-06-30 was -$46.00M.
- Celularity Inc. liabilities, fair value adjustment for the quarter ending 2022-03-31 was $6.41M.
- Celularity Inc. liabilities, fair value adjustment for the quarter ending 2021-12-31 was -$23.30M.
- Celularity Inc. liabilities, fair value adjustment for fiscal 2021 was -$41.15M.
- Celularity Inc. liabilities, fair value adjustment for fiscal 2020 was -$55.57M.
| Period end | Liabilities, Fair Value Adjustment 3 month | Liabilities, Fair Value Adjustment 6 month | Liabilities, Fair Value Adjustment 9 month | Liabilities, Fair Value Adjustment 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$33.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$79.44M derived: sum of 2 quarters · filed 2022-11-10 | -$73.03M 10-Q · filed 2022-11-10 | -$96.33M derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | -$46.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$39.59M 10-Q · filed 2022-08-09 | -$62.89M derived: sum of 3 quarters · filed 2022-08-09 | |
| 2022-03-31 | $6.41M 10-Q · filed 2022-05-16 | -$16.89M derived: sum of 2 quarters · filed 2022-05-16 | ||
| 2021-12-31 | -$23.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$41.15M 10-K · filed 2022-03-31 | ||
| 2021-09-30 | -$17.84M 10-Q · filed 2021-11-12 | |||
| 2020-12-31 | -$55.57M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |